<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00518687</url>
  </required_header>
  <id_info>
    <org_study_id>V710-003</org_study_id>
    <secondary_id>2007_523</secondary_id>
    <nct_id>NCT00518687</nct_id>
  </id_info>
  <brief_title>Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)</brief_title>
  <official_title>A Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the efficacy of a single dose of V710 vaccine to prevent serious
      Staphylococcus aureus infections following elective cardiothoracic surgery. The study will
      also evaluate the immune response and general safety of the V710 vaccine.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Staphylococcus Aureus Bacteremia and/or Deep Sternal Wound Infection</measure>
    <time_frame>Up to 90 days after surgery</time_frame>
    <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the Centers for Disease Control (CDC) Guidelines for Nosocomial infections (Garner JS, Jarvis WS, Emori TG, et al. CDC definitions for nosocomial infections. APIC Infect Control App Epidemiol 1996;A1-20). Bacteremia was defined as ≥1 positive blood culture for S. aureus regardless of the presence of clinical symptoms. A Staphylococcus aureus deep sternal wound infection included mediastinitis or a deep incisional surgical-site infection involving the sternal wound.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Vaccine-related Serious Adverse Experiences</measure>
    <time_frame>Up to 360 days after surgery</time_frame>
    <description>Vaccine-related adverse experiences were those deemed by the investigator to be possibly, probably, or definitely vaccine related. A serious adverse experience was any adverse experience occurring at any dose that 1) resulted in death, 2) was life threatening, 3) resulted in a persistent or significant disability/incapacity, 4) resulted in or prolonged an existing inpatient hospitalization, 5) was a congenital anomaly/birth defect, 6) was a cancer, 7) was an overdose, or 8) jeopardized the participant and required medical or surgical intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Invasive Staphylococcus Aureus Infection</measure>
    <time_frame>Up to 90 days after surgery</time_frame>
    <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. An invasive Staphylococcus infection included bacteremia, deep sternal wound infection, deep-tissue organ/space infection at another surgical site, or any other deep-tissue infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Surgical-site Staphylococcus Aureus Infection</measure>
    <time_frame>Up to 90 days after surgery</time_frame>
    <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. A Staphylococcus infection surgical-site infection included any superficial incisional, deep incisional, or organ/space infection at the sternal site, the vascular harvest (donor) site, or any other site at which the surgery was performed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8031</enrollment>
  <condition>Staphylococcus Aureus</condition>
  <condition>Bacteremia</condition>
  <condition>Mediastinitis</condition>
  <arm_group>
    <arm_group_label>V710 60 µg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>V710</intervention_name>
    <description>0.5-mL single injection of V710 (60 µg)</description>
    <arm_group_label>V710 60 µg</arm_group_label>
    <other_name>Merck 0657nI Staphylococcus aureus vaccine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>0.5-mL single injection of matching placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is scheduled to undergo cardiothoracic surgery involving a full median
             sternotomy (not including cardiac transplantation surgery) within 14 to 60 days after
             vaccination.

          -  Female participants of reproductive potential are required to have a negative urine or
             serum pregnancy test immediately prior to study vaccination and must use an acceptable
             form of birth control.

        Exclusion Criteria:

          -  Participants had an invasive Staphylococcus aureus infection within the past 3 months
             prior to study entry.

          -  A realistic (&gt;50%) possibility that cardiothoracic surgery will be necessary sooner
             than 10 days after vaccination.

          -  Participant is planning to undergo cardiac transplantation surgery or sternal
             debridement to remedy an infection resulting from a prior cardiothoracic surgery.

          -  Participant has any type of ventricular-assist device in place at the time of study
             entry.

          -  Participant has a history of anaphylaxis to any of the vaccine components.

          -  Participant received V710 vaccine, any other investigational Staphylococcus aureus
             vaccine, or investigational Staphylococcus aureus antibodies.

          -  Participant has a temperature of ≥100.4ºF (≥38.0ºC), oral equivalent, within 48 hours
             prior to study vaccination.

          -  Participant has impairment of the immune system.

          -  Participant has a medical condition in which the expected survival is less than 90
             days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Colombia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Guatemala</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2007</study_first_submitted>
  <study_first_submitted_qc>August 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2007</study_first_posted>
  <results_first_submitted>October 2, 2012</results_first_submitted>
  <results_first_submitted_qc>October 2, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 5, 2012</results_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Mediastinitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>V710 60 µg</title>
          <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo : 0.5-ml single injection of matching placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4005">An additional 10 participants were not analyzed because of questionable clinical practices at 1 site</participants>
                <participants group_id="P2" count="4005">An additional 11 participants were not analyzed because of questionable clinical practices at 1 site</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated</title>
              <participants_list>
                <participants group_id="P1" count="3981"/>
                <participants group_id="P2" count="3982"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2568"/>
                <participants group_id="P2" count="2585"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1437"/>
                <participants group_id="P2" count="1420"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="201"/>
                <participants group_id="P2" count="177"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="144"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive disease</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study terminated by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="930"/>
                <participants group_id="P2" count="918"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
                <participants group_id="P2" count="110"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>V710 60 µg</title>
          <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo : 0.5-ml single injection of matching placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4005"/>
            <count group_id="B2" value="4005"/>
            <count group_id="B3" value="8010"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.6" spread="12.6"/>
                    <measurement group_id="B2" value="63.9" spread="12.5"/>
                    <measurement group_id="B3" value="63.8" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1328"/>
                    <measurement group_id="B2" value="1336"/>
                    <measurement group_id="B3" value="2664"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2677"/>
                    <measurement group_id="B2" value="2669"/>
                    <measurement group_id="B3" value="5346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Staphylococcus Aureus Bacteremia and/or Deep Sternal Wound Infection</title>
        <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the Centers for Disease Control (CDC) Guidelines for Nosocomial infections (Garner JS, Jarvis WS, Emori TG, et al. CDC definitions for nosocomial infections. APIC Infect Control App Epidemiol 1996;A1-20). Bacteremia was defined as ≥1 positive blood culture for S. aureus regardless of the presence of clinical symptoms. A Staphylococcus aureus deep sternal wound infection included mediastinitis or a deep incisional surgical-site infection involving the sternal wound.</description>
        <time_frame>Up to 90 days after surgery</time_frame>
        <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
        <group_list>
          <group group_id="O1">
            <title>V710 60 µg</title>
            <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : 0.5-ml single injection of matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Staphylococcus Aureus Bacteremia and/or Deep Sternal Wound Infection</title>
          <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the Centers for Disease Control (CDC) Guidelines for Nosocomial infections (Garner JS, Jarvis WS, Emori TG, et al. CDC definitions for nosocomial infections. APIC Infect Control App Epidemiol 1996;A1-20). Bacteremia was defined as ≥1 positive blood culture for S. aureus regardless of the presence of clinical symptoms. A Staphylococcus aureus deep sternal wound infection included mediastinitis or a deep incisional surgical-site infection involving the sternal wound.</description>
          <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3528"/>
                <count group_id="O2" value="3517"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.584</p_value>
            <p_value_desc>A 1-sided p-value &lt;0.025 implies that the V710 vaccine efficacy is statistically significantly greater than 20%</p_value_desc>
            <method>Exact 1-sided binomial test</method>
            <param_type>Vaccine Efficacy (VE)</param_type>
            <param_value>18.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-48.6</ci_lower_limit>
            <ci_upper_limit>55.8</ci_upper_limit>
            <estimate_desc>VE = 1 - Relative Risk of V710 compared with placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Vaccine-related Serious Adverse Experiences</title>
        <description>Vaccine-related adverse experiences were those deemed by the investigator to be possibly, probably, or definitely vaccine related. A serious adverse experience was any adverse experience occurring at any dose that 1) resulted in death, 2) was life threatening, 3) resulted in a persistent or significant disability/incapacity, 4) resulted in or prolonged an existing inpatient hospitalization, 5) was a congenital anomaly/birth defect, 6) was a cancer, 7) was an overdose, or 8) jeopardized the participant and required medical or surgical intervention.</description>
        <time_frame>Up to 360 days after surgery</time_frame>
        <population>The population analyzed included all vaccinated participants with follow-up results</population>
        <group_list>
          <group group_id="O1">
            <title>V710 60 µg</title>
            <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : 0.5-ml single injection of matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Vaccine-related Serious Adverse Experiences</title>
          <description>Vaccine-related adverse experiences were those deemed by the investigator to be possibly, probably, or definitely vaccine related. A serious adverse experience was any adverse experience occurring at any dose that 1) resulted in death, 2) was life threatening, 3) resulted in a persistent or significant disability/incapacity, 4) resulted in or prolonged an existing inpatient hospitalization, 5) was a congenital anomaly/birth defect, 6) was a cancer, 7) was an overdose, or 8) jeopardized the participant and required medical or surgical intervention.</description>
          <population>The population analyzed included all vaccinated participants with follow-up results</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3958"/>
                <count group_id="O2" value="3967"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.997</p_value>
            <method>Miettinen and Nurminen</method>
            <param_type>Estimated rate difference</param_type>
            <param_value>0.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1</ci_lower_limit>
            <ci_upper_limit>0.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Invasive Staphylococcus Aureus Infection</title>
        <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. An invasive Staphylococcus infection included bacteremia, deep sternal wound infection, deep-tissue organ/space infection at another surgical site, or any other deep-tissue infection.</description>
        <time_frame>Up to 90 days after surgery</time_frame>
        <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
        <group_list>
          <group group_id="O1">
            <title>V710 60 µg</title>
            <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : 0.5-ml single injection of matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Invasive Staphylococcus Aureus Infection</title>
          <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. An invasive Staphylococcus infection included bacteremia, deep sternal wound infection, deep-tissue organ/space infection at another surgical site, or any other deep-tissue infection.</description>
          <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3528"/>
                <count group_id="O2" value="3517"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.347</p_value>
            <p_value_desc>A 1-sided p-value &lt;0.025 implies that the V710 vaccine efficacy is statistically significant</p_value_desc>
            <method>Exact 1-sided binomial test</method>
            <param_type>Vaccine Efficacy (VE)</param_type>
            <param_value>12.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-50.8</ci_lower_limit>
            <ci_upper_limit>50.0</ci_upper_limit>
            <estimate_desc>VE = 1 - Relative Risk of V710 compared with placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Surgical-site Staphylococcus Aureus Infection</title>
        <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. A Staphylococcus infection surgical-site infection included any superficial incisional, deep incisional, or organ/space infection at the sternal site, the vascular harvest (donor) site, or any other site at which the surgery was performed.</description>
        <time_frame>Up to 90 days after surgery</time_frame>
        <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
        <group_list>
          <group group_id="O1">
            <title>V710 60 µg</title>
            <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : 0.5-ml single injection of matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Surgical-site Staphylococcus Aureus Infection</title>
          <description>Diagnosis of the Staphylococcus aureus infections employed standardized definitions adapted from the CDC Guidelines for Nosocomial infections. A Staphylococcus infection surgical-site infection included any superficial incisional, deep incisional, or organ/space infection at the sternal site, the vascular harvest (donor) site, or any other site at which the surgery was performed.</description>
          <population>The population analyzed was the full analysis set: participants who were vaccinated and subsequently underwent cardiothoracic surgery involving full median sternotomy at least 14 days and at most 60 days after vaccination</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3528"/>
                <count group_id="O2" value="3517"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.032</p_value>
            <p_value_desc>A 1-sided p-value &lt;0.025 implies that the V710 vaccine efficacy is statistically significant</p_value_desc>
            <method>Exact 1-sided binomial test</method>
            <param_type>Vaccine Efficacy (VE)</param_type>
            <param_value>29.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.8</ci_lower_limit>
            <ci_upper_limit>51.2</ci_upper_limit>
            <estimate_desc>VE = 1 - Relative Risk of V710 compared with placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All serious adverse events (SAEs): through Day 14 after vaccination; vaccine-related SAEs, SAEs resulting in death, and SAEs involving infection diagnosis: through Day 360 after surgery; other adverse events (AEs): through Day 14 after vaccination</time_frame>
      <desc>The population analyzed was all vaccinated participants with follow-up results</desc>
      <group_list>
        <group group_id="E1">
          <title>V710 (60 µg) Lyophilized</title>
          <description>V710: 0.5-ml single injection of V710 (60 µg)</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo : 0.5-ml single injection of matching placebo</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 14.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="291" subjects_at_risk="3958"/>
                <counts group_id="E2" subjects_affected="274" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3958"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="3958"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3958"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3958"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="3958"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Low cardiac output syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricle rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral arteriovenous malformation haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Device leakage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="31" subjects_affected="31" subjects_at_risk="3958"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cytolytic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Candida sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Endocarditis pseudomonal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Enterococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Fungal endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Klebsiella infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3958"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3958"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Prostatic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pyonephrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3958"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="3958"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3958"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal mediastinitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3958"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Wound infection bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="3958"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Intraoperative cerebral artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Vasoplegia syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cardiac output decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Troponin T increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Basal ganglia infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cerebral disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Dizziness exertional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3958"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm ruptured</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis obliterans</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3958"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3958"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3958"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 14.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="749" subjects_at_risk="3958"/>
                <counts group_id="E2" subjects_affected="343" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" events="285" subjects_affected="280" subjects_at_risk="3958"/>
                <counts group_id="E2" events="104" subjects_affected="102" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="575" subjects_affected="533" subjects_at_risk="3958"/>
                <counts group_id="E2" events="244" subjects_affected="232" subjects_at_risk="3967"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" events="222" subjects_affected="217" subjects_at_risk="3958"/>
                <counts group_id="E2" events="79" subjects_affected="79" subjects_at_risk="3967"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

